Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-018591
Filing Date
2024-07-01
Accepted
2024-07-01 16:36:35
Documents
1
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 form4-07012024_080730.html 4  
1 form4-07012024_080730.xml 4 46002
  Complete submission text file 0001415889-24-018591.txt   47630
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALUMIS INC. 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Bradley Mark Christopher (Reporting) CIK: 0002023657 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42143 | Film No.: 241091183